These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1603493)

  • 1. Estrogen use and depressive symptoms in postmenopausal women.
    Palinkas LA; Barrett-Connor E
    Obstet Gynecol; 1992 Jul; 80(1):30-6. PubMed ID: 1603493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic features of menopausal and postmenopausal applicants for life insurance.
    Schiefeling M
    J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life.
    Gupta P; Sturdee DW; Palin SL; Majumder K; Fear R; Marshall T; Paterson I
    Climacteric; 2006 Feb; 9(1):49-58. PubMed ID: 16428125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen replacement therapy for depression in perimenopausal women.
    Shaukat A; Arain TM; Shahid A; Irfan S; Farrukh S
    J Coll Physicians Surg Pak; 2005 Oct; 15(10):597-600. PubMed ID: 19810294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age, pattern and symptoms of menopause among rural women of Lahore.
    Yahya S; Rehan N
    J Ayub Med Coll Abbottabad; 2002; 14(3):9-12. PubMed ID: 12476855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring climacteric symptoms in an Ecuadorian population with the Greene Climacteric Scale.
    Sierra B; Hidalgo LA; Chedraui PA
    Maturitas; 2005 Jul; 51(3):236-45. PubMed ID: 15978967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in attitudes, knowledge and hormone replacement therapy use: a comparative study in two random samples with 6-year interval.
    Thunell L; Stadberg E; Milsom I; Mattsson LA
    Acta Obstet Gynecol Scand; 2005 Apr; 84(4):395-401. PubMed ID: 15762973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depressive symptoms in climacteric women are related to menopausal symptom intensity and partner factors.
    Chedraui P; Pérez-López FR; Morales B; Hidalgo L
    Climacteric; 2009 Oct; 12(5):395-403. PubMed ID: 19387879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy: a study of women's knowledge and attitudes.
    Sinclair HK; Bond CM; Taylor RJ
    Br J Gen Pract; 1993 Sep; 43(374):365-70. PubMed ID: 8251232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
    Oddens BJ; Boulet MJ
    Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles.
    Cohen LS; Soares CN; Vitonis AF; Otto MW; Harlow BL
    Arch Gen Psychiatry; 2006 Apr; 63(4):385-90. PubMed ID: 16585467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women.
    Matthews KA; Wing RR; Kuller LH; Meilahn EN; Plantinga P
    Arch Intern Med; 1994 Oct; 154(20):2349-55. PubMed ID: 7944857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of depressive symptoms in postmenopausal women with low bone mineral density and/or prevalent vertebral fracture: results from the Multiple Outcomes of Raloxifene Evaluation (MORE) study.
    Silverman SL; Shen W; Minshall ME; Xie S; Moses KH
    J Rheumatol; 2007 Jan; 34(1):140-4. PubMed ID: 17216681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dilemma of menopause and hormone replacement--a challenge for women and health-care providers: knowledge of menopause and hormone therapy in Spanish menopausal women.
    Castelo-Branco C; Peralta S; Ferrer J; Palacios S; Cornago S; Quereda F
    Climacteric; 2006 Oct; 9(5):380-7. PubMed ID: 17000585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depressive disorders and the menopause transition.
    Llaneza P; García-Portilla MP; Llaneza-Suárez D; Armott B; Pérez-López FR
    Maturitas; 2012 Feb; 71(2):120-30. PubMed ID: 22196311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of risk factors and symptoms associated with menopause in Spanish women.
    Pérez JA; Garcia FC; Palacios S; Pérez M
    Maturitas; 2009 Jan; 62(1):30-6. PubMed ID: 19010615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Climacteric medicine: European Menopause and Andropause Society (EMAS) statements on postmenopausal hormonal therapy.
    Skouby SO; Barlow D; Samsioe G; Gompel A; Pines A; Al-Azzawi F; Graziottin A; Hudita D; Rozenberg S;
    Maturitas; 2004 May; 48(1):19-25. PubMed ID: 15223104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormones and menopausal status as predictors of depression in women in transition to menopause.
    Freeman EW; Sammel MD; Liu L; Gracia CR; Nelson DB; Hollander L
    Arch Gen Psychiatry; 2004 Jan; 61(1):62-70. PubMed ID: 14706945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasomotor symptoms and mortality: the Rancho Bernardo Study.
    Svartberg J; von Mühlen D; Kritz-Silverstein D; Barrett-Connor E
    Menopause; 2009; 16(5):888-91. PubMed ID: 19421076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.